Table 2

The number of people with common comorbidities of the complete adult population, adults with T1DM (for comparison), and adults with T2DM

ComorbiditiesAll adults n (%) (N=1 015 867)Adults with T1DM n (%) (N=4478)Adults with T2DM n (%) (N=58 717)
Hypertension164 502 (16.2)967 (21.6)33 467 (57.0)
Atrial fibrillation25 209 (2.5)53 (1.2)5253 (8.9)
Angina17 837 (1.8)83 (1.9)4688 (8.0)
Myocardial infarction11 227 (1.1)73 (1.6)2697 (4.6)
Congestive heart failure11 216 (1.1)61 (1.4)3146 (5.4)
Stroke12 120 (1.2)50 (1.1)2366 (4.0)
Transient ischaemic attack9870 (1.0)28 (0.6)1838 (3.1)
Chronic kidney disease41 054 (4.0)285 (6.4)10 585 (18.0)
Renal replacement therapy1163 (0.1)56 (1.3)312 (0.5)
Dementia9964 (1.0)19 (0.4)1883 (3.2)
Depression95 941 (9.4)657 (14.7)6927 (10.7)
Amputation1799 (0.2)65 (1.5)472 (0.8)
Peripheral neuropathy7170 (0.7)326 (7.3)3847 (6.6)
Retinopathy24 698 (2.4)2667 (59.6)21 396 (36.4)
Peripheral vascular disease6820 (0.7)98 (2.2)2172 (3.7)
Rheumatoid arthritis8519 (0.8)40 (0.9)1028 (1.8)
Chronic liver disease*10 651 (1.0)80 (1.8)2638 (4.5)
NAFLD6530 (0.6)54 (1.2)1989 (3.4)
  • *All liver disease including NAFLD.

  • NAFLD, non-alcoholic fatty liver disease; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.